468 related articles for article (PubMed ID: 26676714)
1. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
[TBL] [Abstract][Full Text] [Related]
2. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.
Wang YM; Chang Y; Chang YY; Cheng J; Li J; Wang T; Zhang QY; Liang DC; Sun B; Wang BM
Neurogastroenterol Motil; 2012 Jun; 24(6):560-5, e254-5. PubMed ID: 22435794
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
[TBL] [Abstract][Full Text] [Related]
4. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
5. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
[TBL] [Abstract][Full Text] [Related]
6. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
7. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis.
Takagi T; Naito Y; Mizushima K; Hirata I; Yagi N; Tomatsuri N; Ando T; Oyamada Y; Isozaki Y; Hongo H; Uchiyama K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S129-33. PubMed ID: 20586854
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis.
Hokari R; Kurihara C; Nagata N; Aritake K; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Urade Y; Miura S
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G401-8. PubMed ID: 21163901
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis.
Santhanam S; Rajamanickam S; Motamarry A; Ramakrishna BS; Amirtharaj JG; Ramachandran A; Pulimood A; Venkatraman A
Inflamm Bowel Dis; 2012 Nov; 18(11):2158-68. PubMed ID: 22374887
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter.
Haub S; Ritze Y; Bergheim I; Pabst O; Gershon MD; Bischoff SC
Neurogastroenterol Motil; 2010 Jul; 22(7):826-34, e229. PubMed ID: 20219086
[TBL] [Abstract][Full Text] [Related]
13. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
[TBL] [Abstract][Full Text] [Related]
14. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
15. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells.
Mizoguchi E
Gastroenterology; 2006 Feb; 130(2):398-411. PubMed ID: 16472595
[TBL] [Abstract][Full Text] [Related]
16. Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.
Ahn JY; Lee KH; Choi CH; Kim JW; Lee HW; Kim JW; Kim MK; Kwon GY; Han S; Kim SE; Kim SM; Chang SK
Dig Dis Sci; 2014 May; 59(5):1001-11. PubMed ID: 24282051
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
[TBL] [Abstract][Full Text] [Related]
18. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
[TBL] [Abstract][Full Text] [Related]
19. The traditional herbal medicine saireito exerts its inhibitory effect on murine oxazolone-induced colitis via the induction of Th1-polarized immune responses in the mucosal immune system of the colon.
Watanabe T; Yamamoto T; Yoshida M; Fujiwara K; Kageyama-Yahara N; Kuramoto H; Shimada Y; Kadowaki M
Int Arch Allergy Immunol; 2010; 151(2):98-106. PubMed ID: 19752563
[TBL] [Abstract][Full Text] [Related]
20. Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity.
Holmén N; Lundgren A; Lundin S; Bergin AM; Rudin A; Sjövall H; Ohman L
Inflamm Bowel Dis; 2006 Jun; 12(6):447-56. PubMed ID: 16775488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
